2019年　欧文

1) Abe K, Shang J, Shi X, Yamashita T, Hishikawa N, Takemoto M, Morihara R, Nakano Y, Ohta Y, Deguchi K, Ikeda M, Ikeda Y, Okamoto K, Shoji M, Takatama M, Kojo M, Kuroda T, Ono K, Kimura N, Matsubara E, Osakada Y, Wakutani Y, Takao Y, Higashi Y, Asada K, Senga T, Lee LJ, Tanaka K. A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology. J Alzheimers Dis. 2020; 73: 217-227.

2) Furuta M, Furuta N, Nagashima K, Fujita Y, Tsushima Y, Ikeda Y. Differential and quantitative neuroimaging characteristics of inclusion body myositis. J Clin Neurosci. 2020; 72:244-251.

3) Tsukagoshi S, Furuta M, Hirayanagi K, Furuta N, Nakazato S, Fujii M, Yuminaka Y, Ikeda Y. Noninvasive and quantitative evaluation of movement disorder disability using an infrared depth sensor. J Clin Neurosci. 2020; 71: 135-140.

4)      Nakamura T, Kawarabayashi T, Seino Y, Hirohata M, Wakabayashi K, Shoji M. Perineuritis Successfully Treated with Early Aggressive Immunotherapy. Intern Med. 2019; 58: 2875-2878.

5) Nagashima K, Makioka K, Fujita Y, Ikeda M, Ikeda Y. Clinical usefulness of scales for evaluating cognitive impairment in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2019; 405: 116414.

6) Todokoro D, Kamei S, Goto H, Ikeda Y, Koyama H, Akiyama H. Acute retinal necrosis following herpes simplex encephalitis: a nationwide survey in Japan. Jpn J Ophthalmol. 2019; 63: 304-309.

7)  Kasahara H, Sato M, Nagamine S, Makioka K, Tanaka K, Ikeda Y. Temporal Changes on ¹²³I-Iomazenil and Cerebral Blood Flow Single-photon Emission Computed Tomography in a Patient with Anti-N-methyl-D-aspartate Receptor Encephalitis. Intern Med. 2019; 58: 1501-1505.

8)  Tsukagoshi S, Sugawara T, Fujisawa Y, Takayama M, Furuta N, Nagashima K, Ikeda Y. Juvenile/adult‐onset galactosialidosis with remarkable clinical variabilities in two Japanese siblings. Neurology and Clinical Neuroscience. 2019; 7: 218-220.

9) Tanaka Y, Ikeda M, Mihara B, Ikeda Y, Sato K, Kitamoto T, Takao M. Importance of Neuropathological Diagnosis of Dementia Patients in Family Practice. JMA journal. 2019; 2: 148-154.

10) Hettmann T, Gillies SD, Kleinschmidt M, Piechotta A, Makioka K, Lemere CA, Schilling S, Rahfeld JU, Lues I. Development of the clinical candidate PBD-C06, a humanized pGlu3-Aβ-specific antibody against Alzheimer's disease with reduced complement activation. Sci Rep. 2020; 10: 3294.